氨基苯乙酮给药后肝功能检查的评估。
Evaluation of liver function tests after administration of aminophenazone.
作者信息
Bien E, Skorka G, Buntrock P
出版信息
Arch Toxicol Suppl. 1980;4:341-2. doi: 10.1007/978-3-642-67729-8_72.
PMID:6933932
Abstract
Known liver function tests (activities of ASAT = L-Aspartate: 2-oxoglutarate aminotransferase, ALAT = L-Alanine: 2-oxoglutarate aminotransferase, GLDH = Glutamate-dehydrogenase, LDH = Lactate-dehydrogenase in serum) are not qualified for detecting minimal histopathological liver alterations induced by aminophenazon.
摘要
已知的肝功能测试（血清中谷草转氨酶=L-天冬氨酸：2-氧代戊二酸氨基转移酶、谷丙转氨酶=L-丙氨酸：2-氧代戊二酸氨基转移酶、谷氨酸脱氢酶、乳酸脱氢酶的活性）不适合检测由氨基非那宗引起的最小组织病理学肝脏改变。
Zotero 插件